{"identifier":"nobleid:/d1/20260526/577C01EB","arkIdentifier":"ark:/48914/d1/20260526/577C01EB","version":1,"workTitle":"Faculty Opinions recommendation of Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics.","workType":"Dataset","authors":"Michael L. Doyle","description":"Published: 2016-10-25 | Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","workUrl":"https://doi.org/10.3410/f.726616466.793524653","existingDoi":"https://doi.org/10.3410/f.726616466.793524653","createdAt":"2026-05-26T15:14:21.325824Z","canonicalUrl":"https://nobleid.org/ark:/48914/d1/20260526/577C01EB.v1"}